Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
TOP Trial of trastuzumab optimization after first-line trastuzumab-based chemotherapy in HER2-positive advanced or metastatic breast cancer
2007-005021-30Phase 3Terminated
- Sponsor
- Regione Lombardia
- Start
- Nov 2007
- Modality
- Monoclonal Antibodies → Antibody-Based Therapeutics
- Countries
- 1
01
Overview
Phase 3, randomised, open-label trial of trastuzumab in breast cancer (4 arms), sponsored by Regione Lombardia. Primary endpoints: Progression-free survival, Overall survival and 3 more. Started Nov 2007; status: terminated.
02
Drugs
03
Conditions
breast cancer
Beyond the preview
Go deeper on 2007-005021-30.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2007-005021-30.